LECTURES AND INVITED TALKS

  1. Quantifying clinical pain – why pain is more than just a rating from 0 to 10. Precision Imaging Beacon Seminar Series (virtual due to COVID). Nottingham, UK. 2021.
  2. Understanding mechanisms responsible for shoulder pain. Center for Neuroplasticity and Pain, CNAP. Aalborg, Denmark. 2018.
  3. How neuroimaging can help us to understand chronic pain. Institute of Psychology, Jagiellonian University. Cracow, Poland. 2018.
  4. Ethical and Practical Considerations for and Against Placebo Control in the Assessment of the Effectiveness of Physical and Surgical Analgesic Interventions - topical workshop with Prof Luana Colloca and Prof Lene Vase. 17th IASP World Congress on Pain. Boston, USA. 2018.
  5. Fake surgeries and dummy pills - control for bias and study design in trials on treatment efficacy in chronic pain - part of the Introduction to Study Design and Research Methods module. MSc in Evidence-Based Health Care. Oxford, UK. 2018.
  6. A placebo control group in surgical randomised controlled trials - when is it useful, ethical and necessary? Wounds Research Network (WReN) 3rd Scientific Meeting. Newcastle, UK. 2018.
  7. If the pain is an experience why is it measured on a scale from 0 to 10. LMH Med Society Meeting. Oxford, UK. 2018.
  8. Can and should placebo control be used in randomised controlled trials of surgical, physical and neuromodulation interventions? The 6th International Congress on Neuropathic Pain (NeuPSIG). Gothenburg, Sweden. 2017.
  9. Has the paper been retracted? - a presentation of retraction flags in electronic journals. NDPCHS Christmas Seminar. Oxford, UK. 2017.
  10. Placebo controls in surgery. BAPRAS Winter Scientific Meeting. London, UK. 2016.
  11. Ethical issues of sham surgery for orthopaedic surgery. Bioethics/HRA workshop on the use of sham surgery Nuffield Council on Bioethics. London, UK. 2015.
  12. Neuroimaging of pain. The ECST PhD Training. Oxford, UK. 2014.
  13. Changes in pain processing in patients with chronic shoulder pain.The Research Seminar Day Musculoskeletal BRU/BRC. 2013. Oxford, UK. 2013.
  14. What did we learn from neuroimaging? Professional Network of the Chartered Society of Physiotherapy Conference. 2012. London, UK
  15. Functional Imaging of Analgesic Drug Development. Boehringer Ingelheim. Oxford, UK. 2012.
  16. Imaging and quantifying pain. The Study in Interdisciplinary Pain Research (SIMPAR). Pavia, Italy. 2011.
  17. Imaging pain in rheumatoid arthritis. Oxford Musculoskeletal Biomedical Research Unit Pain Symposium. Oxford, UK. 2011.
  18. Exploratory discussions in CNS and Inflammation. UCB visit. Oxford, UK. 2011.
  19. How pain emerges from the brain: a neuroimaging window. The 3rd International Palliative Medicine Conference. Galway, Ireland. 2011.
  20. Functional neuroimaging findings in osteoarthritis and other peripheral pain states.Pain and Musculoskeletal Disorders: Translating Scientific Advances into Practice. Washington DC, USA. 2010.
  21. The experience of pain: a neuroimaging perspective on understanding the subjective experience of pain and modulation of pain processing. Medical Anthropology seminars. Oxford, UK. 2010.
  22. Advantages of using magnetic resonance imaging to understand pain mechanisms. Pain Education Meeting. London, UK. 2010.
  23. Where is chronic pain? Prescribing for Chronic Pain - Theory and Practice Meeting of the Royal Society of Medicine. London, UK. 2010.
  24. Neuroimaging and clinical pain (a keynote address). Pain Symposium, Barts and The London. London, UK. 2009.
  25. An academic perspective: advantages of using magnetic resonance imaging to understand pain mechanisms and in analgesic drug development – talk at the 4th Annual Global Imaging Summit: Optimising Imaging Techniques in Preclinical and Clinical Drug Development. Cologne, Germany. 2008.
  26. Functional magnetic resonance imaging and perception of pain. Diabetes UK Annual Professional Conference. Glasgow, UK. 2008.
  27. Imaging and pain: general principles. ARC Research Strategy Workshop: Mechanisms of Pain in Arthritis, Manchester, UK. 2007.
  28. Pain and imaging - neural networks involved in the subjective experience of pain. The 26th UCP Symposium. Groningen, The Netherlands. 2007.
  29. Pain and imaging. Wessex and Southwest Pain Society Meeting. Bath, UK. 2007.
  30. FMRI for drug discovery - working meeting on the use of MRI in drug development. The International Society for Magnetic Resonance in Medicine Conference. Berlin, Germany. 2007.
  31. Providing an insight into the diagnosis and treatment of pain conditions - Pain Therapeutics conference, London, UK. 2006.
  32. Imaging in analgesic drug development and understanding chronic pain mechanisms - Global Imaging Summit, Optimizing Imaging Techniques in Preclinical and Clinical Drug Development. Zurich, Switzerland. 2006.

WORKSHOPS

  1. "Is Nocebo Placebo's Evil Twin?" – a workshop on the nocebo effect in pain and biomedical research (Chair: Wartolowska K, Organisers: Wartolowska K, Colloca L, Amanzio M), IASP World Congress on Pain (virtual due to COVID). 2021.
  2. "How can Placebo Control be Implemented in Trials of Surgery?" – a workshop on the placebo-controlled non-pharmacological trials on pain conditions (Chair: Wartolowska K; organisers: Wartolowska K, Vase L, Harris I, O'Connell N, Eldabe S), IASP World Congress on Pain (virtual due to COVID).2021.
  3. "Ethical and practical considerations of placebo control in the assessment of the effectiveness of physical and surgical analgesic interventions" – a workshop on the placebo-controlled trials. (Chair: Vase L, Organisers: Wartolowska K, Vase L, Colloca L), IASP World Congress on Pain, Boston, USA. 2018.
  4. "Producing data-driven tools" – a workshop at the Evidence Live conference organised with Ben Goldacre, Seb Bacon, Helen Curtis, Richard Croker, Nicholas DeVito, Alex Walker. Oxford, UK. 2017.

CONFERENCE PRESENTATIONS

  1. Wartolowska K and Webb AJS. Regional diffusion imaging changes related to obesity, after adjusting for other risk factors: the UK Biobank study. The 31th ISMRM Conference. London, UK. 2022.
  2. Wartolowska K and Webb AJS. Complex interactions between obesity and white matter: UK Biobank study. European Stroke Organisation. Virtual due to COVID. 2021.
  3. Parepalli S, Sweeney O, Mirtorabi N, Loo Yong Kee K, Feakins BG, Aronson JK, Wartolowska K. Placebo’s invisible brother – a restricted scoping review of biomedical literature on the nocebo effect (a poster). World Congress on Pain. Virtual due to COVID. 2021.
  4. Wartolowska K and Webb AJS. Effect of past and concurrent blood pressure above 120/70 on white matter hyperintensities: an analysis of the UK Biobank cohort. European Stroke Organisation-World Stroke Organisation Conference. Vienna, Austria. (virtual due to COVID). 2020.
  5. Wartolowska K and Webb AJS. Differential associations between macroscopic and microstructural white matter injury with constant and pulsatile blood pressure components: an analysis of the UK Biobank cohort. European Stroke Organisation-World Stroke Organisation Virtual Conference. Vienna, Austria. Virtual due to COVID. 2020.
  6. Croal PL, Ray KJ, Wartolowska K, Lawson A, Webb A, Jezzard P. Physiological correlates of brain pulsatility in cerebrovascular small vessel disease: a data-driven approach with high temporal resolution fMRI. ISMRM & SMRT Virtual Conference & Exhibition. 2020.
  7. Wartolowska K and Webb AJS. Mid-life diastolic blood pressure predicts excess future white matter hyperintensities more than systolic blood pressure: an analysis of the UK Biobank cohort. The Brain Prize Meeting: “Silently Loosing the Brain”. The Lundbeck Foundation. Copenhagen, Denmark. 2019.
  8. Wartolowska K, Gerry S, Feakins BG, Collins GS, Cook J, Judge A, Carr AJ Temporal characteristics of effect size in the placebo arm of surgical randomised controlled trials - a meta-analysis (a talk). Evidence Live Conference. Oxford, UK. 2017.
  9. Wanigasekera V, Wartolowska K, Huggins J, Duff E, Vennart W, Whitlock M, Massat N, Pauer L, Rogers P, Hoggart B Disruption of Placebo Neural Networks by Centrally Acting Analgesics in Neuropathic Pain Patients (a poster). The 16th World Congress on Pain. Yokohama, Japan. 2016.
  10. Wartolowska K, Gallois J, Carr AJ Structural brain changes in patients with shoulder impingement syndrome (a poster). The Challenges in Chronic Pain, Wellcome Trust Genome Campus. Cambridge, UK. 2015.
  11. Wartolowska K, Judge A, Dean B Rombach I, Savulescu J, Beard D, Carr A The use of placebo in randomised surgical clinical trials (a poster). The 2nd Clinical Trials Methodology Conference: Methodology Matters. Edinburgh, UK. 2013. Trials 2013;14(Suppl 1):P38.
  12. Wartolowska K, Judge A, Dean B, Rombach I, Savulescu J, Beard D, Carr A Benefits and harms of placebo in surgical randomised clinical trials: a systematic review (a poster). The 2nd Clinical Trials Methodology Conference: Methodology Matters. Edinburgh, UK. 2013. Trials 2013;14(Suppl1):P39.
  13. Beard D, Cooper C, Rombach I, Rees J, Wartolowska K, Cummings N, Carr A Accounting for the placebo effect of surgery in surgical trials? (a poster). The 2nd Clinical Trials Methodology Conference: Methodology Matters. Edinburgh, UK. 2013. Trials 2013;14(Suppl 1):P11-P11
  14. Wartolowska K, Wordsworth BP, Tracey I. Limbic structures and response to anti-TNF treatment (a poster). \textit{The 7th Congress of the European Federation of IASP Chapters (EFIC)}. Hamburg, Germany. 2011. European Journal of Pain Supplements
  15. Johnston KD, Russell E, Ramaswamy KK, Wartolowska K, Madder H. Audit of the use and efficacy of noninvasive cooling in a neurosurgical intensive care unit. (a poster). Annual Scientific Meeting of the Neuroanaesthesia Society of Great Britain and Ireland. Newcastle, UK. 2011. [Journal of Neurosurgical Anesthesiology 2011;23:283]
  16. Wartolowska K, Hough MG, Wordsworth BP, Tracey I. Changes in the subcortical grey matter in rheumatoid arthritis (a poster). The Joint Annual Scientific Meeting of the British Pain Society and the Canadian Pain Society. Edinburgh, UK. 2011.
  17. Wartolowska K, Hough MG, Wordsworth P, Tracey I. Structural Brain Changes in Rheumatoid Arthritis (a poster). The 13th World Congress on Pain, International Association for the Study of Pain. Montreal, Canada. 2010.
  18. Wartolowska K, Hough MG, Wordsworth P, Tracey I. Structural Brain Changes in Patients with Rheumatoid Arthritis (a poster). The 6th Congress of the European Federation of the International Association for the Study of Pain Chapter(EFIC). Lisbon, Portugal. 2009. European Journal of Pain 2009;13:S134.
  19. Wartolowska K, Wordsworth P, Schweinhardt P, Chizh BA, Chessell IP, Tracey I. Pain Processing in Rheumatoid Arthritis Patients Successfully Treated with Anti-TNF Medication (a poster). The 6th Congress of the European Federation of the International Association for the Study of Pain Chapter (EFIC). Lisbon, Portugal. 2009. European Journal of Pain 2009; 13:S134a-134.
  20. Wartolowska K, Schweinhardt P, Wordsworth P, Chizh BA, Chessell IP, Tracey I. Cerebral processing of pain in rheumatoid arthritis patients treated with antiTNF-alpha (a poster). The 12th International Congress on Pain, IASP. Glasgow, UK. 2008.
  21. Tracey I, Schweinhardt P, McQuay H, Wartolowska K Functional MRI as a Tool for Diagnosis in Neuropathic Pain (a talk). The 2nd International Congress of the Special Interest Group on Neuropathic Pain. Berlin, Germany. 2007. European Journal of Pain 2007; 11(1):24-24
  22. Wartolowska K, Schweinhardt P, Wordsworth P, Chizh BA, Bountra C, Chessell IP, Tracey I. Clinical and experimental pain processing in RA patients treated with anti-TNF (a talk). Annual Meeting of the British Society for Rheumatology (BSR). Birmingham, UK Young Investigator Award. 2007. Rheumatology 2007; 46:I6-I7
  23. Wartolowska K, Schweinhardt P, Wordsworth P, Chizh BA, Bountra C, Chessell IP, Tracey I. Changes in brain activation related to pain relief in rheumatoid arthritis patients following the anti-TNF treatment (a poster). The 5th Congress of the European Federation of IASP Chapters (EFIC). Istanbul, Turkey. 2006. European Journal of Pain 2006; 10(S1) S84.
  24. Walczak A, Berkowicz T, Wartolowska K, Sieger M, Zaleski K, Selmaj K. Effect of Mitoxantrone therapy on T1 lesion load and atrophy in multiple sclerosis patients. The 22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). Madrid, Spain. 2006. [Multiple Sclerosis 2006:12(S1):S171]
  25. Cvoro V, Wardlaw JM, Wartolowska K, Farrall AJ, Marshall I, Armitage PA, Rivers CS, Bastin ME, Carpenter TK, Dennis MS. Lactate values in the acute stroke diffusion lesion vary with perfusion levels. The 15th European Stroke Conference. Brussels, Belgium. 2006.
  26. Wardlaw JM, Karaszewski BC, Marshall I, Cvoro V, Wartolowska K, Haga K, Armitage PA, Bastin ME. Dennis MS. Measurement of brain temperature with MR spectroscopy in patients with acute ischaemic stroke - temperature is highest in "penumbral" tissue. British Society of Neuroradiologists Annual Scientific Meeting. Edinburgh, UK. 2005.
  27. Marshall I, Karaszewski B, Wardlaw JM, Cvoro V, Wartolowska K, Armitage PA, Carpenter T, Bastin M, Farrall A, Haga K, Dennis M. Measurement of regional brain temperature using proton spectroscopic imaging: preliminary results in acute ischaemic stroke. European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) Conference. Basel, Switzerland. 2005.
  28. Berkowicz T, Karlinska I, Wartolowska K, Zaleski K, Selmaj K. A multiple sclerosis case with predominant cortical lesions. The 9th Congress of the European Federation of Neurological Societies (EFNS). Athens, Greece. 2005.
  29. Berkowicz T, Walczak A, Wartolowska K, Siger-Zajdel M, Zaleski K, Selmaj K. Effects of Mitoxantrone therapy on MRI picture in multiple sclerosis. The 19th Conference of the Polish Neurological Society. Lodz, Poland. 2005.

BLOGS

  1. Fake surgeries and dummy pills - bias control and study design in trials of treatment efficacy. Evidence-based Health Care podcasts, University of Oxford. 2018.
  2. Unreported trial of the week: ketorolac vs nepafenac after cataract surgery (NCT02752646). 2018. The BMJ Opinion. 2018.
  3. Electrical shavers and splashed saline – how blinding has been achieved in surgical placebo-controlled trials. F1000 blognetwork. 2017.
  4. Randomised Placebo-Controlled Trials of Surgery: Ethical Analysis and Guidelines. Journal of Medical Ethics Forum. 2016.
  5. Use of placebo controls in the evaluation of surgery: a systematic review. Oxford Clinical Trials Research Unit. 2014.

PUBLIC OUTREACH

  1. A presentation on the subjective nature of pain using the Schmidt Pain Index as an example. Curiosity Carnival. Oxford, UK.
  2. "Our brain and pain" - an article for chronic pain patients Chronic Pain Ireland. Galway, Ireland.
  3. Taster Day talk about pain, brain imaging, and neuroscience for pupils from the Countesthorpe College and Netherstowe School. Oxford, UK.
  4. "The mind is its own place ..." - a talk for pupils. Dr Challoner's High School. Chalfont Latimer, UK
  5. "Neuroscience update on pain mechanisms and relationship to dentistry" - a talk for the Newbury Study Group. Newbury, UK.
  6. "Ouch! The science of pain" -- a talk for the general public. ScienceOxford. Oxford, UK.

Home